News

Sloan-Kettering Institute Director Thomas J. Kelly
Thomas Kelly Honored

Sloan-Kettering Institute Director Thomas J. Kelly is the co-recipient of the 2010 Louisa Gross Horwitz Prize from Columbia University.

Friday, April 1, 2011
Study Elucidates How Antibiotics Can Increase Some Harmful Infections in Cancer Patients

An interdisciplinary team from Memorial Sloan-Kettering Cancer Center has shown how antibiotics can disrupt the normal, healthy balance of microorganisms in the gastrointestinal tract.

Friday, April 1, 2011
Viviane S. Tabar
Memorial Sloan-Kettering Researchers Show Brain Tumors Make Their Own Blood Vessels from Stem Cells

Memorial Sloan-Kettering Cancer Center researchers have published new findings that may help explain why brain tumors called glioblastomas are so resistant to treatment.

Friday, April 1, 2011
Treating Rare Cancers

Memorial Sloan-Kettering physicians have experience and specialized expertise in caring for people with uncommon cancers.

Friday, April 1, 2011
Pictured: Sensory Neurons
New Center for Stem Cell Biology Launched

A new center at the Sloan-Kettering Institute is exploring the potential of embryonic stem cells and human adult cells to produce regenerative treatments and provide insights into cancer.

Friday, April 1, 2011
Novel Immunotherapy Drug Receives FDA Approval for the Treatment of Metastatic Melanoma

The US Food and Drug Administration announced today that the drug ipilimumab (brand name Yervoy) has been approved for the treatment of patients with metastatic melanoma. It is the first drug ever shown to improve overall survival for patients with advanced melanoma.

Friday, March 25, 2011
Pictured: Dimiter Tassev
First Gerstner Sloan-Kettering Student Receives PhD Degree

Dimiter Tassev, a member of Gerstner Sloan-Kettering’s inaugural class, has completed all his degree requirements and will receive his PhD in May.

Tuesday, March 1, 2011
Memorial Sloan-Kettering President Craig Thompson Welcomes Prospective Gerstner Sloan-Kettering Students

Memorial Sloan-Kettering Cancer Center and Gerstner Sloan-Kettering President Craig Thompson and his wife opened their home for a reception for prospective Gerstner Sloan-Kettering students invited for admissions interviews.

Tuesday, February 1, 2011
Novel Cancer-Targeting Investigational Nanoparticle Receives FDA IND Approval for First-In-Human Trial

Researchers at Memorial Sloan-Kettering Cancer Center’s Nanotechnology Center, along with collaborators at Cornell University and Hybrid Silica Technologies, have received approval for their first Investigational New Drug Application (IND) from the US Food and Drug Administration (FDA) for an ultrasmall silica inorganic nanoparticle platform for targeted molecular imaging of cancer, which may be useful for cancer treatment in the future.

Monday, January 31, 2011
Memorial Sloan-Kettering Researchers Are 2010 Rock Stars of Science

Three Memorial Sloan-Kettering Cancer Center investigators — including the Center’s new President, Craig B. Thompson — have been featured with singer-songwriter Debbie Harry to lead the Geoffrey Beene Gives Back® 2010 Rock Stars of Science™ campaign in GQ magazine’s December “Men of the Year” issue.

Saturday, January 1, 2011